• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BAFF/APRIL 系统:超越 B 细胞生物学和自身免疫的新兴功能。

The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.

机构信息

Department of Immunology, Monash University, Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria 3004, Australia.

出版信息

Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15. doi: 10.1016/j.cytogfr.2013.04.003. Epub 2013 May 15.

DOI:10.1016/j.cytogfr.2013.04.003
PMID:23684423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7108297/
Abstract

The BAFF system plays a key role in the development of autoimmunity, especially in systemic lupus erythematosus (SLE). This often leads to the assumption that BAFF is mostly a B cell factor with a specific role in autoimmunity. Focus on BAFF and autoimmunity, driven by pharmaceutical successes with the recent approval of a novel targeted therapy Belimumab, has relegated other potential roles of BAFF to the background. Far from being SLE-specific, the BAFF system has a much broader relevance in infection, cancer and allergy. In this review, we provide the latest views on additional roles of the BAFF system in health and diseases, as well as an update on BAFF and autoimmunity, with particular focus on current clinical trials.

摘要

BAFF 系统在自身免疫的发展中起着关键作用,特别是在系统性红斑狼疮(SLE)中。这往往导致人们认为 BAFF 主要是一种 B 细胞因子,在自身免疫中具有特定的作用。由于最近批准了一种新型靶向治疗药物贝利木单抗(Belimumab)在制药方面取得了成功,因此对 BAFF 和自身免疫的关注已经将 BAFF 的其他潜在作用置于次要地位。BAFF 系统远非 SLE 所特有,它在感染、癌症和过敏等方面具有更广泛的相关性。在这篇综述中,我们提供了关于 BAFF 系统在健康和疾病中的其他作用的最新观点,以及对 BAFF 和自身免疫的最新更新,特别关注当前的临床试验。

相似文献

1
The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.BAFF/APRIL 系统:超越 B 细胞生物学和自身免疫的新兴功能。
Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15. doi: 10.1016/j.cytogfr.2013.04.003. Epub 2013 May 15.
2
BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.BAFF-R 和 TACI 在 CD3+T 细胞上的表达:系统性红斑狼疮中 BAFF、APRIL 与辅助性 T 细胞细胞因子谱之间的相互作用。
Cytokine. 2019 Feb;114:115-127. doi: 10.1016/j.cyto.2018.11.008. Epub 2018 Nov 19.
3
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.在系统性红斑狼疮及其他抗体相关疾病中靶向作用于B淋巴细胞刺激因子(BAFF)和增殖诱导配体(APRIL)。
Int Rev Immunol. 2017 Jan 2;36(1):3-19. doi: 10.1080/08830185.2016.1276903.
4
Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.系统性红斑狼疮外周血B细胞亚群上BAFF、APRIL血清水平、BAFF-R、TACI和BCMA表达与临床表现的相关性
Lupus. 2016 May;25(6):582-92. doi: 10.1177/0961203315608254. Epub 2015 Sep 29.
5
A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.系统性红斑狼疮小鼠模型对可溶性TACI的反应比对可溶性BAFFR的反应更好,这与浆细胞的耗竭相关。
Eur J Immunol. 2017 Jun;47(6):1075-1085. doi: 10.1002/eji.201746934. Epub 2017 Apr 24.
6
Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.中国系统性红斑狼疮患者中 BAFF/BAFF 受体的表达及其与疾病活动的相关性。
Lupus. 2010 Nov;19(13):1534-49. doi: 10.1177/0961203310375268.
7
B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus Erythematosus.B 细胞成熟抗原(BCMA)作为系统性红斑狼疮的生物标志物和潜在治疗靶点。
Int J Mol Sci. 2024 Oct 9;25(19):10845. doi: 10.3390/ijms251910845.
8
[BAFF/APRIL pathway in Sjögren syndrome and systemic lupus erythematosus: relationship with chronic inflammation and disease activity].干燥综合征和系统性红斑狼疮中的BAFF/APRIL信号通路:与慢性炎症和疾病活动的关系
Reumatismo. 2010 Oct-Dec;62(4):259-65. doi: 10.4081/reumatismo.2010.259.
9
The BAFF/APRIL system in SLE pathogenesis.SLE 发病机制中的 BAFF/APRIL 系统。
Nat Rev Rheumatol. 2014 Jun;10(6):365-73. doi: 10.1038/nrrheum.2014.33. Epub 2014 Mar 11.
10
BAFF, APRIL and their receptors: structure, function and signaling.B细胞活化因子、增殖诱导配体及其受体:结构、功能与信号传导
Semin Immunol. 2006 Oct;18(5):263-75. doi: 10.1016/j.smim.2006.04.006. Epub 2006 Aug 17.

引用本文的文献

1
Severe pulmonary arterial hypertension development despite lupus nephritis remission: association with podocytic infolding glomerulopathy.尽管狼疮性肾炎缓解,但仍发生严重肺动脉高压:与足细胞内褶肾小球病的关联。
BMC Nephrol. 2025 Aug 30;26(1):503. doi: 10.1186/s12882-025-04428-1.
2
Exploring the role of APRIL in autoimmunity: implications for therapeutic targeting in systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome.探索增殖诱导配体(APRIL)在自身免疫中的作用:对系统性红斑狼疮、类风湿关节炎和干燥综合征治疗靶点的启示
Front Immunol. 2025 Aug 1;16:1523392. doi: 10.3389/fimmu.2025.1523392. eCollection 2025.
3

本文引用的文献

1
A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis.一项为期52周的开放标签研究,评估抗B细胞活化因子单克隆抗体他巴鲁单抗治疗类风湿关节炎的安全性和有效性。
Arthritis Res Ther. 2014 Aug 29;16(4):415. doi: 10.1186/s13075-014-0415-2.
2
Mcl-1 is essential for the survival of plasma cells.Mcl-1 对于浆细胞的存活至关重要。
Nat Immunol. 2013 Mar;14(3):290-7. doi: 10.1038/ni.2527. Epub 2013 Feb 3.
3
Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial.
Opportunities and challenges in the treatment of IgA nephropathy.
IgA肾病治疗中的机遇与挑战。
Front Pharmacol. 2025 Jul 30;16:1559593. doi: 10.3389/fphar.2025.1559593. eCollection 2025.
4
MSM Supplementation Is Associated with Reduced Inflammation and Improved Innate Immune Response following In Vitro LPS-Stimulation in Humans after a Bout of Downhill Running.在一次下坡跑后,补充甲基磺酰甲烷(MSM)与人体体外脂多糖(LPS)刺激后炎症减轻及固有免疫反应改善相关。
Muscles. 2023 May 6;2(2):204-217. doi: 10.3390/muscles2020015.
5
Efficacy and safety of telitacicept in systemic lupus erythematosus with lupus nephritis and nephrotic syndrome: a 12-month retrospective cohort study.泰它西普治疗狼疮性肾炎和肾病综合征的系统性红斑狼疮的疗效与安全性:一项为期12个月的回顾性队列研究
Front Pharmacol. 2025 Jul 18;16:1613790. doi: 10.3389/fphar.2025.1613790. eCollection 2025.
6
Diagnostic accuracy of bone-related biomarkers on peri-implantitis: potential of A-proliferation-inducing ligand.骨相关生物标志物对种植体周围炎的诊断准确性:A增殖诱导配体的潜力
BMC Oral Health. 2025 Jul 25;25(1):1240. doi: 10.1186/s12903-025-06578-y.
7
Molecular mechanisms of unique therapeutic potential of CUDC-907 for MEF2D fusion-driven BCP-ALL.CUDC-907对MEF2D融合驱动的B细胞前体急性淋巴细胞白血病独特治疗潜力的分子机制
Signal Transduct Target Ther. 2025 Jul 23;10(1):230. doi: 10.1038/s41392-025-02310-y.
8
Age-related inflammatory biomarkers in early-onset osteoporosis in females with Gaucher disease.戈谢病女性早发性骨质疏松症中与年龄相关的炎症生物标志物
Front Endocrinol (Lausanne). 2025 Jul 2;16:1606218. doi: 10.3389/fendo.2025.1606218. eCollection 2025.
9
Telitacicept for systemic lupus erythematosus: protocol of a systematic review and meta-analysis.泰它西普治疗系统性红斑狼疮:一项系统评价与荟萃分析方案
BMJ Open. 2025 Jul 16;15(7):e090646. doi: 10.1136/bmjopen-2024-090646.
10
The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances.B细胞活化因子系统在自身免疫性疾病中的作用:机制、疾病影响及治疗进展
Front Immunol. 2025 Jun 6;16:1538555. doi: 10.3389/fimmu.2025.1538555. eCollection 2025.
对于对甲氨蝶呤反应不足且未接受过生物治疗的类风湿关节炎患者,使用他巴鲁单抗的一项II期随机安慰剂对照试验。
Arthritis Rheum. 2013 Apr;65(4):880-9. doi: 10.1002/art.37820.
4
Intravenous immunoglobulin inhibits BAFF production in chronic inflammatory demyelinating polyneuropathy - a new mechanism of action?静脉注射免疫球蛋白抑制慢性炎症性脱髓鞘性多发性神经病中 BAFF 的产生 - 一种新的作用机制?
J Neuroimmunol. 2013 Mar 15;256(1-2):84-90. doi: 10.1016/j.jneuroim.2013.01.001. Epub 2013 Jan 26.
5
Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease.血清 BAFF 和 APRIL 可能与抗肾小球基底膜病患者的疾病活动和肾脏损伤有关。
Nephrology (Carlton). 2013 Mar;18(3):209-14. doi: 10.1111/nep.12032.
6
B-cell-activating factor is a regulator of adipokines and a possible mediator between adipocytes and macrophages.B 细胞激活因子是脂肪因子的调节剂,也是脂肪细胞和巨噬细胞之间的可能介质。
Exp Mol Med. 2013 Jan 10;45(1):e4. doi: 10.1038/emm.2013.4.
7
Natural Immunity to HIV: a delicate balance between strength and control.对HIV的天然免疫:强度与控制之间的微妙平衡。
Clin Dev Immunol. 2012;2012:875821. doi: 10.1155/2012/875821. Epub 2012 Dec 11.
8
CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.CD19(+)CD21(low) B 细胞与具有细支气管炎性闭塞综合征的 NIH 定义的慢性移植物抗宿主病风险患者。
Blood. 2013 Mar 7;121(10):1886-95. doi: 10.1182/blood-2012-06-435008. Epub 2013 Jan 9.
9
Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes.滤泡性淋巴瘤中 BAFF 和 BAFF-R 的表达:与临床病理特征和生存结局的相关性。
PLoS One. 2012;7(12):e50936. doi: 10.1371/journal.pone.0050936. Epub 2012 Dec 13.
10
Induction of BAFF expression by IFN-γ via JAK/STAT signaling pathways in human intestinal epithelial cells.IFN-γ 通过 JAK/STAT 信号通路诱导人肠上皮细胞中 BAFF 的表达。
J Leukoc Biol. 2013 Mar;93(3):363-8. doi: 10.1189/jlb.0412210. Epub 2012 Dec 27.